Phase II study of erlotinib in patients with advanced biliary cancer

Philip A. Philip, Michelle R. Mahoney, Cristine Allmer, James Thomas, Henry C. Pitot, George Kim, Ross C. Donehower, Tom Fitch, Joel Picus, Charles Erlichman

Research output: Contribution to journalArticlepeer-review

254 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of erlotinib in patients with advanced biliary cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences